Boston Scientific announced plans to reduce its workforce in an effort to achieve $500 million in annual cost savings. The company aims to streamline operations and refocus investments to drive future growth. Details regarding the scope and locations of the job cuts were not immediately available, but the company indicated this is a strategic move. Executives believe these adjustments will position Boston Scientific for “solid growth” in the coming years. The company anticipates the full impact of these changes to be realized by 2028. This restructuring suggests a broader trend of cost-cutting within the medical device industry as companies navigate economic pressures and evolving market dynamics. The ultimate goal is to improve profitability and competitiveness.